Clin2
NCT07179237Likely a fitRecruiting

Testing carminal for H. pylori stomach infection

H Pylori GastritisH Pylori InfectionH Pylori EradicationGastritis Associated With Helicobacter PyloriGastric Mucosal Lesion

Part of Digestive system clinical trials.

This trial tests a new medicine called carminal for people with stomach inflammation caused by H. pylori bacteria. It aims to see if the drug can help improve symptoms like indigestion and get rid of the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have indigestion symptoms like pain, bloating, or burning in your stomach
  • You have been diagnosed with H. pylori stomach infection through an upper endoscopy with biopsy
  • You are not currently pregnant, breastfeeding, or planning to become pregnant during the study
  • You do not have an active ulcer, previous stomach surgery, or a history of cancer

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07012785Not yet recruiting
Yeast plus antibiotic for new H. pylori infections

This trial tests whether taking a special yeast (Saccharomyces boulardii) together with an antibiotic (minocycline) clears a first-time H. pylori stomach infection. It may help reduce side effects and improve treatment success.

Nanjing, Jiangsu
NCT04713670Recruiting· Phase 4
Tested medicines to cure new H. pylori infection

This trial compares different stomach-medicine combinations to eliminate a new (first-time) H. pylori infection. It may help find the most effective treatment approach for people who have never tried eradication therapy before.

Taipei
NCT07344506Recruiting· Phase 4
Cure H. pylori: New combination therapy for stomach infection

This trial tests a new combination of medications to treat H. pylori, a common stomach infection that can cause ulcers. It aims to find a more effective treatment with fewer side effects.

Karachi
NCT06777732Not yet recruiting· Early Phase 1
Testing a new medicine for clearing H. pylori stomach infection

This study tests a new medicine called Keverprazan, which may help get rid of the H. pylori bacteria that causes stomach ulcers and other problems. If you have H. pylori and haven't been treated before, this trial could help you clear the infection with a new approach.

NCT07068607Recruiting· Phase 4
Comparing two treatments for H. pylori infection

This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.

Xi'an, Shaanxi
NCT07606833Not yet recruiting· Phase 3
Combination therapy for helicobacter pylori infection

This trial tests a new medication combined with standard antibiotics and bismuth to treat helicobacter pylori, a bacteria that can cause stomach ulcers. It aims to see if this combination is safe and effective in clearing the infection.

Shenzhen, Guangdong

Hear when a new H. Pylori Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.